We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Optimizing Antibody Drug Development With Machine Learning

News   Apr 16, 2021 | Original story from ETH Zurich

 
Optimizing Antibody Drug Development With Machine Learning

Machine learning helps develop optimal antibody drugs. Credit: ETH Zurich

 
 
Advertisement
 

RELATED ARTICLES

Microneedles for Painless Drug Delivery With Minimal Side Effects

News

A study published in the Journal of Controlled Release discusses recent advancements of microneedles for cancer immunotherapy delivery.

READ MORE

Restricting the Growth and Spread of Head and Neck Cancers

News

Researchers have discovered that CD276 allows cancer stem cells to bypass the body's natural immune defenses, spurring the growth and spread of head and neck squamous cell cancers.

READ MORE

Enzyme That Is Critical for Kidney Health Could Help 700 Million People Worldwide

News

University of South Australia researchers have identified an enzyme that may help to curb chronic kidney disease, which affects approximately 700 million people worldwide.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE